Its tech talent and endogamous cohorts make it unique.

Keeping America’s lead in biotech depends on fixing what's broken about the policy status quo — and not breaking what works, ...

Chapters of FFA, once called Future Farmers of America, are becoming more common in city schools. Program advisors say students are learning skills that can help them work in a wide range of ...

In the healthcare and biotechnology space, your brand’s search strategy not only amplifies the commercial reach of your innovation, but it also amplifies the ability for it to make a lasting impact on ...

Vinay Prasad, an official for the Food and Drug Administration, is reportedly stepping down, which is welcome news for ...

Gil Efron to Step Down as CEO in August 2026 for Health Considerations; Will Continue to Lead Corporate Development ...

Gil Efron to Step Down as CEO in August 2026 for Health Considerations; Will Continue to Lead Corporate Development REHOVOT, Israel, March 13, 2026 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (NASDAQ/TASE ...

The National Defense Authorization Act stresses the need for coordination with NATO allies, many of whom are actively pursuing such biotech advancements. At the same time, NATO’s Defense Innovation ...

When you're looking to add growth to your portfolio, you may immediately think of technology stocks -- and this is a great idea. But technology stocks aren't the only players that may supercharge your ...

The Food and Drug Administration's controversial vaccine chief, Dr. Vinay Prasad, is once again leaving the agency.

The move comes as BioNTech shifts to being a multiproduct commercial biotech, allowing Ugur Sahin and Özlem Türeci to transition back into research on next-generation mRNA therapeutics.